BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23363476)

  • 1. Lower circulating preptin levels in male patients with osteoporosis are correlated with bone mineral density and bone formation.
    Li N; Zheng YB; Han J; Liang W; Wang JY; Zhou JR; Shen Y; Zhang J
    BMC Musculoskelet Disord; 2013 Jan; 14():49. PubMed ID: 23363476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinol-binding protein 4 is positively associated with bone mineral density in patients with type 2 diabetes and osteopenia or osteoporosis.
    Huang N; Zhou J; Wang W; Wang Q; Tang Y; Sun Y; Wang D; Chen S
    Clin Endocrinol (Oxf); 2018 May; 88(5):659-664. PubMed ID: 29394455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone turnover in passive smoking female rat: relationships to change in bone mineral density.
    Gao SG; Li KH; Xu M; Jiang W; Shen H; Luo W; Xu WS; Tian J; Lei GH
    BMC Musculoskelet Disord; 2011 Jun; 12():131. PubMed ID: 21663694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.
    Malluche HH; Davenport DL; Cantor T; Monier-Faugere MC
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1254-62. PubMed ID: 24948144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
    Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ
    Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of metabolic bone disease in patients with endogenous hyperthyroidism: role of biological markers of bone turnover.
    Jódar Gimeno E; Muñoz-Torres M; Escobar-Jiménez F; Quesada Charneco M; Luna del Castillo JD; Oleà N
    Calcif Tissue Int; 1997 Nov; 61(5):370-6. PubMed ID: 9351877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M; Fukunaga M; Ohtawa T; Harada T
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of bone mineral density in stable kidney transplant recipients.
    Gupta AK; Huang M; Prasad GV
    J Nephrol; 2012; 25(3):373-83. PubMed ID: 21928224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
    Mori Y; Kasai H; Ose A; Serada M; Ishiguro M; Shiraki M; Tanigawara Y
    Osteoporos Int; 2018 May; 29(5):1155-1163. PubMed ID: 29423715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related changes of serum tartrate-resistant acid phosphatase 5b and the relationship with bone mineral density in Chinese women.
    Qin YJ; Zhang ZL; Zhang H; Hu WW; Liu YJ; Hu YQ; Li M; Gu JM; He JW
    Acta Pharmacol Sin; 2008 Dec; 29(12):1493-8. PubMed ID: 19026169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An association between abnormal bone turnover, systemic inflammation, and osteoporosis in patients with chronic pancreatitis: a case-matched study.
    Duggan SN; Purcell C; Kilbane M; O'Keane M; McKenna M; Gaffney P; Ridgway PF; Boran G; Conlon KC
    Am J Gastroenterol; 2015 Feb; 110(2):336-45. PubMed ID: 25623657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low bone mineral density in men with chronic obstructive pulmonary disease.
    Duckers JM; Evans BA; Fraser WD; Stone MD; Bolton CE; Shale DJ
    Respir Res; 2011 Aug; 12(1):101. PubMed ID: 21812978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density.
    Lage S; Bueno M; Andrade F; Prieto JA; Delgado C; Legarda M; Sanjurjo P; Aldámiz-Echevarría LJ
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S363-71. PubMed ID: 20830525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suitability of tartrate-resistant acid phosphatase type 5b as a screening marker for bone mineral density in community-dwelling elderly individuals.
    Irie S; Hayashida N; Shinkawa T; Taira Y; Sekitani Y; Teraoka S; Hashiguchi K; Yoshida K; Morishita M; Takamura N
    Tohoku J Exp Med; 2011 Jun; 224(2):105-10. PubMed ID: 21597244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the relation between bone mass density and serum preptin levels in pre- and postmenopausal women.
    Nazari Soltan Aahmad S; Nourollahi S; Kazerouni F; Kianmehr N; Hajipour H; Sanajou D; Hosseini V
    J Bone Miner Metab; 2018 Nov; 36(6):710-715. PubMed ID: 29134283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum carcinoembryonic antigen-related cell adhesion molecule 1 level in postmenopausal women: correlation with β-catenin and bone mineral density.
    Ma C; Shuai B; Shen L; Yang YP; Xu XJ; Li CG
    Osteoporos Int; 2016 Apr; 27(4):1529-1535. PubMed ID: 26572758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density.
    Cohen A; Recker RR; Lappe J; Dempster DW; Cremers S; McMahon DJ; Stein EM; Fleischer J; Rosen CJ; Rogers H; Staron RB; Lemaster J; Shane E
    Osteoporos Int; 2012 Jan; 23(1):171-82. PubMed ID: 21365462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional markers, not markers of bone turnover, are related predictors of bone mineral density in chronic peritoneal dialysis patients.
    Jeong JU; Lee HK; Kim YJ; Kim JS; Kang SS; Kim SB
    Clin Nephrol; 2010 Nov; 74(5):336-42. PubMed ID: 20979940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical factors associated with bone mass loss previous cardiac transplantation].
    García Delgado I; Gil-Fraguas L; Robles E; Martínez G; Hawkins F
    Med Clin (Barc); 2000 May; 114(20):761-4. PubMed ID: 10923320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.